Idea principal
Pooling 65 studies with 1,550,524 participants and 86,201 cancer cases, neither short sleep (OR 1.01, 95% CI 0.97-1.05) nor long sleep (OR 1.02, 95% CI 0.97-1.07) was linked to higher cancer risk. Two subgroup findings (short sleep in Asians, long sleep and colorectal cancer) did not hold up in the dose-response analysis.
Study design
Revisión de evidencia
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Short and long sleep have been linked to disease, but whether sleep duration affects cancer risk has been disputed. The authors pooled published studies, comparing sleep duration categories and also modelling risk per hour of sleep.
Población y método
Systematic review and meta-analysis. PubMed, EMBASE and the Cochrane Library were searched up to July 2017 for population-based cohort and case-control studies with at least three categories of sleep duration. Sixty-five studies from 25 articles were included. Categorical meta-analysis compared short and long sleep with a reference, subgroup analyses looked at region and cancer type, and a dose-response analysis used two linear segments with a 7 hour cut point. The abstract does not define the sleep categories.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Neither short nor long sleep duration was associated with cancer overall: short sleep OR 1.01 (95% CI 0.97-1.05), long sleep OR 1.02 (95% CI 0.97-1.07).
- 2In subgroups, short sleep was associated with cancer among Asians (OR 1.36, 95% CI 1.02-1.80), and long sleep with colorectal cancer (OR 1.21, 95% CI 1.08-1.34).
- 3The dose-response analysis found no significant relationship: OR 1.02 (95% CI 0.98-1.07) per 1 hour less sleep and OR 1.003 (95% CI 0.97-1.03) per 1 hour more, using a 7 hour cut point.
Límites e incertidumbre
- 1The subgroup findings come from many splits of the data, so they may be chance results, and they were not consistent in the dose-response analysis.
- 2Sleep duration in the pooled studies is likely self-reported at a single point in time, and the abstract does not say how it was measured.
- 3Case-control and cohort studies are pooled, and cannot establish that sleep affects cancer or the reverse; the authors call for trials and prospective studies.
- 4This reading is based on the abstract only.
Relevancia práctica
This analysis gives little reason to think your nightly sleep length on its own predicts cancer, while the colorectal and Asian-subgroup signals remain unconfirmed. Sleep matters for other health reasons, and concerns about cancer risk belong in a conversation with your clinician.
Tus datos
Sleep trackers estimate total sleep time reasonably over weeks but with error, and the studies here relied on a different kind of data. Use the same device and look at your average over weeks, not single nights.
Cómo interpretar la evidencia
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
The effect of sleep duration on cancer risk remains controversial. We aimed to quantify the available evidence on this relationship using categorical and dose-response meta-analyses.
Methods
Population-based cohort studies and case-control studies with at least three categories of sleep duration were identified by searching PubMed, EMBASE, and the Cochrane Library database up to July 2017.
Results
Sixty-five studies from 25 articles were included, involving 1,550,524 participants and 86,201 cancer cases. The categorical meta-analysis revealed that neither short nor long sleep duration was associated with increased cancer risk (short: odds ratio [OR] = 1.01, 95% confidence intervals [CI] = 0.97-1.05; long: OR = 1.02, 95% CI = 0.97-1.07). Subgroup analysis revealed that short sleep duration was associated with cancer risk among Asians (OR = 1.36; 95% CI: 1.02-1.80) and long sleep duration significantly increased the risk of colorectal cancer (OR = 1.21; 95% CI: 1.08-1.34). The dose-response meta-analysis showed no significant relationship between sleep duration and cancer risk. When treated as two linear piecewise functions with a cut point of 7 h, similar nonsignificant associations were found (per 1-h reduction: OR = 1.02, 95% CI = 0.98-1.07; per 1-h increment: OR = 1.003, 95% CI = 0.97-1.03).
Conclusion
Categorical meta-analysis indicated that short sleep duration increased cancer risk in Asians and long sleep duration increased the risk of colorectal cancer, but these findings were not consistent in the dose-response meta-analysis. Long-term randomized controlled trials and well-designed prospective studies are needed to establish causality and to elucidate the mechanism underlying the association between sleep duration and cancer risk.
Fuentes y atribución
Sleep duration and the risk of cancer: a systematic review and meta-analysis including dose-response relationship.
Chen Y, Tan F, Wei L, Li X, Lyu Z, Feng X, Wen Y, Guo L, He J, Dai M, Li N.
BMC cancer · 2018-11-21
DOI: 10.1186/s12885-018-5025-y ↗PubMed · 30463535 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

